drugset / Trial / NCT06232109

Drug-Drug Interaction of ASN51 With Fluvoxamine, Itraconazole and Paroxetine in Healthy Subjects

NCT06232109

Phase 1 Completed 50 enrolled Asceneuron S.A.
Non-randomizedParallel-groupOpen-labelTreatment

Summary

The drug-drug interaction study has been designed to investigate the effect of Fluvoxamine, Itraconazole and Paroxetine on the pharmacokinetics of ASN51

Timeline

Start
2024-02-22
Primary completion
2024-07-03
Completion
2024-07-03

Drugs

EvaluationDrugModalityDoseRoute
Subject ASN51 Unknown Oral
Subject Fluvoxamine Unknown Oral
Subject Itraconazole Small molecule Oral
Subject Paroxetine Small molecule Oral

Indications

No indication recorded.